UVSL.NS stock at INR 0.20 on NSE 25 Feb 2026: heavy volume marks most-active intraday trading
Intraday most-active update: UVSL.NS stock at INR 0.20 on NSE with volume 204,817,737 and Meyka AI forecast
-
-
Mishcon de Reya: Court Tosses Contempt Bid, Negligence Denied — February 25
Mishcon de Reya gains relief as the High Court tosses a contempt claim and negligence is denied, easing near-term risk for UK legal services and litigation funders.
-
Sony Group (6758.T JPX) at JPY 3306.00 on 25 Feb 2026 market closed: heavy volume marks most-active trade
6758.T stock report: JPY 3306.00, -0.90%, volume 28,076,300. Most-active JPX close on 25 Feb 2026
-
8211.HK Zhejiang Yongan Rongtong (HKSE) +23.68% after hours 25 Feb 2026: watch volume surge for short-term momentum
After-hours surge: 8211.HK stock up 23.68% to HK$0.047 on high volume; valuation and forecast analysis
-
February 25: Marc Dutroux Probe Spurs EU Prison Security Scrutiny
February 25: Belgium’s probe into Marc Dutroux for alleged abuse images in prison spotlights EU prison security. What German investors should know about procurement, technologies, and EU justicepolicy
-
Pre-Market 25 Feb 2026: L.TO Loblaw (TSX) earnings spotlight: key numbers ahead
Pre-market look at L.TO stock ahead of Loblaw earnings on 25 Feb 2026, price, Meyka forecast and grade
-
AWC.AX Alumina Limited ASX drops to A$1.45 on 25 Feb 2026: active volume signals near-term test
AWC.AX stock at A$1.45 on 25 Feb 2026 with heavy volume; analysis, forecast and risks for ASX investors
-
LLOY.L Stock Today: February 25 — Scraps Post Office Cheque Deposits
Lloyds bank cheque deposit at Post Office counters has ended as Lloyds Banking Group advances 95 UK branch closures. What this means for customers and investors in LLOY.L today.
-
PSYBF (PsyBio PNK) -99.98% to $0.000001 on 25 Feb 2026: next steps
PSYBF stock falls 99.98% to $0.000001 on 25 Feb 2026. Meyka AI analysis, metrics and short-term outlook
-
H.C. Wainwright Maintains Buy on ORIC (ORIC Pharmaceuticals, Inc.) Feb 2026
H.C. Wainwright maintained Buy and raised ORIC price target to $25 on Feb 24, 2026 — ORIC analyst rating update
